Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Dellepiane

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vaccine|December 5, 2013
Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectivesNora Dellepiane, David Wood
Vaccine|April 28, 2019
Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspectiveNora Dellepiane, Sonia Pagliusi,
Vaccine|May 5, 2018
Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processesNora Dellepiane, Sonia Pagliusi,
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|August 7, 2018
Joint evaluation of marketing authorization files of inactivated polio vaccines in countries of the Eastern Mediterranean RegionHouda Langar, Razieh Ostad Ali Dehaghi, Nora Dellepiane
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt CountriesNora Dellepiane, Bartholomew Dicky Akanmori, Sunil Gairola, et al.
Vaccine|January 23, 2002
Vaccine quality--can a single standard be defined?Julie Milstien, Nora Dellepiane, Scott Lambert, et al.
Vaccine: X|September 30, 2020
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturersNora Dellepiane, Sonia Pagliusi, Prashant Akut, et al.
Vaccine|February 19, 2022
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situationMic McGoldrick, Thierry Gastineau, Diane Wilkinson, et al.
Vaccine|February 19, 2022
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situationMic McGoldrick, Thierry Gastineau, Diane Wilkinson, et al.
Vaccine|May 22, 2012
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experienceMamoudou H Djingarey, Rodrigue Barry, Mete Bonkoungou, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|December 5, 2013
Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectivesNora Dellepiane, David Wood
Vaccine|April 28, 2019
Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspectiveNora Dellepiane, Sonia Pagliusi,
Vaccine|May 5, 2018
Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processesNora Dellepiane, Sonia Pagliusi,
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|August 7, 2018
Joint evaluation of marketing authorization files of inactivated polio vaccines in countries of the Eastern Mediterranean RegionHouda Langar, Razieh Ostad Ali Dehaghi, Nora Dellepiane
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt CountriesNora Dellepiane, Bartholomew Dicky Akanmori, Sunil Gairola, et al.
Vaccine|January 23, 2002
Vaccine quality--can a single standard be defined?Julie Milstien, Nora Dellepiane, Scott Lambert, et al.
Vaccine: X|September 30, 2020
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturersNora Dellepiane, Sonia Pagliusi, Prashant Akut, et al.
Vaccine|February 19, 2022
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situationMic McGoldrick, Thierry Gastineau, Diane Wilkinson, et al.
Vaccine|February 19, 2022
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situationMic McGoldrick, Thierry Gastineau, Diane Wilkinson, et al.
Vaccine|May 22, 2012
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experienceMamoudou H Djingarey, Rodrigue Barry, Mete Bonkoungou, et al.
Pageof 1